Cohort study on 20 years’ experience of bilateral video- assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients

Autores

Palavras-chave:

Hyperhidrosis, Quality of life, Thoracoscopy

Resumo

BACKGROUND: Primary hyperhidrosis is a condition characterized by excessive sweating, inconsistent with the needs for thermoregulation. OBJECTIVE: To assess the effectiveness and the change in the quality of life of patients undergoing bilateral VATS (video-assisted thoracoscopic sympathectomy) for treatment of hyperhidrosis, in a large case series. DESIGN AND SETTING: Cohort study conducted in a tertiary hospital specializing in hyperhidrosis located in São Paulo, Brazil. METHODS: A total of 2,431 patients who underwent surgery consisting of bilateral video-assisted thoracoscopic sympathectomy between January 2000 and February 2017 were retrospectively assessed in an outpatient clinic specializing in hyperhidrosis. The patients underwent clinical and quality of lie assessments on two occasions: firstly, prior to surgery, and subsequently, one month after the operation. The presence or absence of compensatory hyperhidrosis (CH) and general satisfaction after the first postoperative month were also evaluated. RESULTS: All the patients operated had poor or very poor quality of life before surgery. In the postoperative period, an improvement in the quality of life was observed in more than 90% of the patients. Only 10.7% of the patients did not present CH, and severe CH occurred in 22.1% of the patients in this sample. CONCLUSIONS: Bilateral VATS is a therapeutic method that decreases the degree of sweating more than 90% of patients with palmar and axillary hyperhidrosis. It improves the quality of life for more than 90% of the patients, at the expense of development of CH in approximately 90% of the patients, but not intensely.

Downloads

Não há dados estatísticos.

Biografia do Autor

Nelson Wolosker, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Full Professor, Hospital Israelita Albert Einstein (HIAE), São Paulo (SP), Brazil; and Surgeon, Department of Surgery, Vascular and Endovascular Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

José Ribas Milanez de Campos, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Surgeon, Hospital Israelita Albert Einstein (HIAE), São Paulo (SP), Brazil; and Surgeon, Department of Surgery, Thoracic Surgery Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Paulo Kauffman, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Surgeon, Hospital Israelita Albert Einstein (HIAE), São Paulo (SP), Brazil; and Surgeon, Department of Surgery, Vascular and Endovascular Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Marcelo Fiorelli Alexandrino da Silva, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD. Surgeon, Hospital Israelita Albert Einstein (HIAE), São Paulo (SP), Brazil; and Surgeon, Department of Surgery, Vascular and Endovascular Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Carolina Brito Faustino, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD. Surgeon, Hospital Israelita Albert Einstein (HIAE), São Paulo (SP), Brazil; and Surgeon, Department of Surgery, Vascular and Endovascular Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Miguel Lia Tedde, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Surgeon, Department of Surgery, Thoracic Surgery Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Pedro Puech-Leão, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Surgeon, Department of Surgery, Vascular and Endovascular Division, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

Paulo Manuel Pêgo Fernandes, Faculdade de Medicina da Universidade de Sao Paulo and Hospital Israelita Albert Einstein

MD, PhD. Full Professor, Thoracic Surgery Program, Instituto do Coração (InCor), Hospital das Clínicas (HC), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo (SP), Brazil; and Cardiothoracic Surgeon, Hospital Beneficência Portuguesa (BP), São Paulo (SP), Brazil.

Referências

Cameron AE. Selecting the Right Patient for Surgical Treatment of Hyperhidrosis. Thorac Surg Clin. 2016;26(4):403-6. PMID: 27692198; https://doi.org/10.1016/j.thorsurg.2016.06.004

Wolosker N, de Campos JR, Kauffman P, et al. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6. PMID: 22047833; https://doi.org/10.1016/j.jvs.2011.07.097

Cerfolio RJ, de Campos JR, Bryant AS, et al. The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642-8. PMID: 21524489; https://doi.org/10.1016/j.athoracsur.2011.01.10

Dias LI, Miranda EC, Toro IF, Mussi RK. Relationship between anxiety, depression and quality of life with the intensity of reflex sweating after thoracoscopic sympathectomy for treatment of primary hyperhidrosis. Rev Col Bras Cir. 2016;43(5):354-9. PMID: 27982329; https://doi.org/10.1590/0100-69912016005013

Dharmaraj B, Kosai NR, Gendeh H, Ramzisham AR, Das S. A Prospective Cohort Study on Quality of Life after Endoscopic Thoracic Sympathectomy for Primary Hyperhidrosis. Clin Ter. 2016;167(3):67-71. PMID: 27424505; https://doi.org/10.7417/CT.2016.1928

Ong W, Lee A, Tan WB, Lomanto D. Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis. Surgical Endoscopy. 2016;30(3):1219-25. PMID: 26150222; https://doi.org/10.1007/s00464-015-4335-2

Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg. 2014;148(5):2443-4. PMID: 25444213; https://doi.org/10.1016/j.jtcvs.2014.08.025

Wolosker N, Yazbek G, de Campos JRM, et al. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis. J Vasc Surg. 2010;51(5):1190-4. PMID: 20299178; https://doi.org/10.1016/j.jvs.2009.11.078

Lee SS, Lee YU, Lee J-H, Lee JC. Comparison of the Long-Term Results of R3 and R4 Sympathicotomy for Palmar Hyperhidrosis. Korean J Thorac Cardiovasc Surg. 2017;50(3):197-201. PMID: 28593156; https://doi.org/10.5090/kjtcs.2017.50.3.197

Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci. 2000;37(1):25-31. PMID: 10857268.

Campos JRM de, Kauffman P, Werebe E de C, et al. Questionnaire of quality of life in patients with primary hyperhidrosis. Jornal de Pneumologia. 2003;29(4):178-81.

de Campos JRM, Kauffman P, Werebe E de C, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886–91. PMID: 12963223; https://doi.org/10.1016/s0003-4975(03)00895-6

Estevan FA, Wolosker MB, Wolosker N, Puech-Leão P. Epidemiologic analysis of prevalence of the hyperhidrosis. An Bras Dermatol. 2017;92(5):630-4. PMID: 29166497; https://doi.org/10.1590/abd1806-4841.20175551

Wolosker N, Krutman M, Kauffman P, et al. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients. Rev Assoc Med Bras (1992). 2013;59(2):143-7. PMID: 23582555; https://doi.org/0.1016/j.ramb.2012.11.002

Wolosker N, de Campos JRM, Kauffman P, et al. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013;52(5):620-3. PMID: 23590378; https://doi.org/10.1111/j.1365-4632.2012.05746.x

Wolosker N, Teivelis MP, Krutman M, et al. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years. Pediatr Dermatol. 2015;32(5):663-7. PMID: 25490865; https://doi.org/10.1111/pde.12385

de Moura Júnior NB, das-Neves-Pereira JC, de Oliveira FRG, et al. Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis. Ann Thorac Surg. 2013;95(2):465-70. PMID: 23219256; https://doi.org/10.1016/j.athoracsur.2012.10.068

Wolosker N, Schvartsman C, Krutman M, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48-53. PMID: 23627681; https://doi.org/10.1111/pde.12142

Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ. 2005;172(1):69-75. PMID: 15632408; https://doi.org/10.1503/cmaj.1040708

Sammons JE, Khachemoune A. Axillary hyperhidrosis: a focused review. J Dermatolog Treat. 2017;28(7):582-90. PMID: 28318360; https://doi.org/10.1080/09546634.2017.1309347

Karimian-Teherani D, Panhofer P, Ringhofer C, et al. New epidemiological aspects of patients with severe hyperhidrosis presenting for sympathetic surgery. J Eur Acad Dermatol Venereol. 2009;23(6):651-5. PMID: 19250333; https://doi.org/10.1111/j.1468-3083.2009.03131.x

Wolosker N, Krutman M, Campdell TPDA, et al. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders. Einstein (Sao Paulo). 2012;10(4):405-8. PMID: 23386077; https://doi.org/10.1590/s1679-45082012000400002

de Campos JRM, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116-20. PMID: 15834768; https://doi.org/10.1007/s10286-005-0259-6

Teivelis MP, Wolosker N, Krutman M, et al. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics (Sao Paulo). 2014;69(9):608-14. PMID: 25318092; https://doi.org/10.6061/clinics/2014(09)06

Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12. PMID: 24512855; https://doi.org/10.1016/j.avsg.2013.12.024

Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. PMID: 25427685; https://doi.org/10.1007/s10286-014-0264-8

Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6. PMID: 25387496; https://doi.org/10.1590/abd1806-4841.20143272

Ribas Milanez de Campos J, Kauffman P, Wolosker N, et al. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J Laparoendosc Adv Surg Tech A. 2006;16(6):598-603. PMID: 17243877; https://doi.org/10.1089/lap.2006.16.598

Yazbek G, Wolosker N, Milanez de Campos JR, et al. Palmar hyperhidrosis—which is the best level of denervation using video-assisted thoracoscopic sympathectomy: T2 or T3 ganglion? J Vasc Surg. 2005;42(2):281-5. PMID: 16102627; https://doi.org/10.1016/j.jvs.2005.03.041

Milanez de Campos JR, Kauffman P, Gomes O, Wolosker N. Video-Assisted Thoracic Sympathectomy for Hyperhidrosis. Thorac Surg Clin. 2016;26(3):347-58. PMID: 27427529; https://doi.org/10.1016/j.thorsurg.2016.04.010

Teivelis MP, Wolosker N, Krutman M, et al. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin. Ann Thorac Surg. 2014;98(5):1797-802. PMID: 25173719; https://doi.org/10.1016/j.athoracsur.2014.05.087

Vannucci F, Araújo JA. Thoracic sympathectomy for hyperhidrosis: from surgical indications to clinical results. J Thorac Dis. 2017;9(Suppl 3):S178-92. PMID: 28446983; https://doi.org/10.21037/jtd.2017.04.04

de Andrade Filho LO, Kuzniec S, Wolosker N, et al. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis of 1731 cases. Ann Vasc Surg. 2013;27(4):447-53. PMID: 23406790; https://doi.org/10.1016/j.avsg.2012.05.026

Leiderman DBD, Milanez de Campos JR, Kauffman P, et al. The relation between age and outcomes of thoracic sympathectomy for hyperhidrosis: The older the better. J Thorac Cardiovasc Surg. 2018;156(4):1748-56. PMID: 30054140; https://doi.org/10.1016/j.jtcvs.2018.05.084

Lembrança L, Wolosker N, de Campos JRM, et al. Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure. Ann Vasc Surg. 2017;43:283-7. PMID: 28478174; https://doi.org/10.1016/j.avsg.2017.01.018

Weng W, Liu Y, Li J, et al. A long-term evaluation of postoperative moist hands after R4/R4+5 sympathectomy for primary palmar hyperhidrosis. J Thorac Dis. 2018;10(3):1532-7. PMID: 29707303; https://doi.org/10.21037/jtd.2018.02.07

Wade R, Jones-Diette J, Wright K, Layton AM, Woolacott N. Hyperhidrosis quality of life measures: review and patient perspective. J Dermatolog Treat. 2019;30(3):303-8. PMID: 30051732; https://doi.org/10.1080/09546634.2018.1506080

Downloads

Publicado

2022-03-03

Como Citar

1.
Wolosker N, Campos JRM de, Kauffman P, Silva MFA da, Faustino CB, Tedde ML, Puech-Leão P, Pêgo Fernandes PM. Cohort study on 20 years’ experience of bilateral video- assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients. Sao Paulo Med J [Internet]. 3º de março de 2022 [citado 14º de março de 2025];140(2):284-9. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/909

Edição

Seção

Artigo Original